State of New Jersey Common Pension Fund D’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-25,896
| Closed | -$1.04M | – | 1721 |
|
|
2026
Q1 | $1.04M | Buy |
25,896
+33
| +0.1% | +$711 | ﹤0.01% | 1397 |
|
|
2025
Q4 | $650K | Buy |
+25,863
| New | +$607K | ﹤0.01% | 1428 |
|
|
2024
Q4 | – | Sell |
-49,795
| Closed | -$1.44M | – | 1544 |
|
|
2024
Q3 | $1.44M | Buy |
49,795
+4,554
| +10% | +$169K | 0.01% | 1503 |
|
|
2024
Q2 | $1.74M | Buy |
45,241
+2,820
| +7% | +$128K | 0.01% | 1408 |
|
|
2024
Q1 | $2.49M | Sell |
42,421
-10,643
| -20% | -$678K | 0.01% | 1469 |
|
|
2023
Q4 | $3.18M | Sell |
53,064
-8,457
| -14% | -$429K | 0.01% | 921 |
|
|
2023
Q3 | $2.34M | Buy |
61,521
+10,328
| +20% | +$454K | 0.01% | 1262 |
|
|
2023
Q2 | $4.66M | Sell |
51,193
-3,902
| -7% | -$337K | 0.02% | 689 |
|
|
2023
Q1 | $3.63M | Sell |
55,095
-2,808
| -5% | -$162K | 0.01% | 766 |
|
|
2022
Q4 | $2.99M | Buy |
57,903
+3,069
| +6% | +$163K | 0.01% | 856 |
|
|
2022
Q3 | $3.75M | Buy |
54,834
+3,991
| +8% | +$236K | 0.02% | 720 |
|
|
2022
Q2 | $2.3M | Sell |
50,843
-8,383
| -14% | -$382K | 0.01% | 1166 |
|
|
2022
Q1 | $3.01M | Sell |
59,226
-4,708
| -7% | -$208K | 0.01% | 1017 |
|
|
2021
Q4 | $3.02M | Buy |
63,934
+20,250
| +46% | +$797K | 0.01% | 1072 |
|
|
2021
Q3 | $1.44M | Sell |
43,684
-4,773
| -10% | -$268K | ﹤0.01% | 1683 |
|
|
2021
Q2 | $3.06M | Sell |
48,457
-1,902
| -4% | -$98.1K | 0.01% | 1045 |
|
|
2021
Q1 | $2.16M | Sell |
50,359
-12,993
| -21% | -$615K | 0.01% | 1514 |
|
|
2020
Q4 | $3.62M | Sell |
63,352
-19,888
| -24% | -$841K | 0.01% | 901 |
|
|
2020
Q3 | $2.51M | Buy |
83,240
+22,670
| +37% | +$677K | 0.01% | 1015 |
|
|
2020
Q2 | $1.98M | Sell |
60,570
-17,133
| -22% | -$550K | 0.01% | 1427 |
|
|
2020
Q1 | $2.08M | Hold |
77,703
| – | – | 0.01% | 1005 |
|
|
2019
Q4 | $2.38M | Sell |
77,703
-6,397
| -8% | -$177K | 0.01% | 1264 |
|
|
2019
Q3 | $2.03M | Buy |
+84,100
| New | +$2.31M | 0.01% | 1388 |
|
Other funds holding APLS
State of New Jersey Common Pension Fund D's APLS Position: Q2 2026 in Review
State of New Jersey Common Pension Fund D sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 25,896 shares — an estimated $1.04M sold.
State of New Jersey Common Pension Fund D first reported a position in APLS in Q3 2019 and held it in 23 quarters. The position peaked at $4.66M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- State of New Jersey Common Pension Fund D reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- State of New Jersey Common Pension Fund D sold 25,896 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.04M.
- State of New Jersey Common Pension Fund D first reported a position in Apellis Pharmaceuticals in Q3 2019 and held it in 23 quarters.
- State of New Jersey Common Pension Fund D's Apellis Pharmaceuticals position peaked at $4.66M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.